Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease that remains incurable. Although the etiologies of ALS are diverse and the precise pathogenic mechanisms are not fully understood, approximately 20% of ALS cases are caused by genetic factors. Therefore, advancing targeted...
Saved in:
| Main Authors: | Qingjian Xie, Kezheng Li, Yinuo Chen, Yaojia Li, Wenhua Jiang, Wen Cao, Huan Yu, Dongsheng Fan, Binbin Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Translational Neurodegeneration |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40035-025-00477-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homozygous mice with mutant protein FUS[1-359] overexpression: Innovative possibilities for ALS treatment
by: Nikita S. Zhunusov
Published: (2024-12-01) -
DOK7 gene therapy enhances motor activity and life span in ALS model mice
by: Sadanori Miyoshi, et al.
Published: (2017-05-01) -
A rare case of juvenile amyotrophic lateral sclerosis
by: Muhittin Bodur, et al.
Published: (2021-06-01) -
Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®
by: Andreia Gomes-Duarte, et al.
Published: (2025-07-01) -
The history behind ALS type 8: from the first phenotype description to the discovery of VAPB mutation
by: Luiz Eduardo NOVIS, et al.
Published: (2021-06-01)